Oncological Outcomes in Men With Favorable Intermediate Risk Prostate Cancer Enrolled in Active Surveillance

PIETRO PEPE; LUDOVICA PEPE; MICHELE PENNISI; FILIPPO FRAGGETTA

doi:10.21873/invivo.13569

Research ArticleClinical Studies

Open Access

Oncological Outcomes in Men With Favorable Intermediate Risk Prostate Cancer Enrolled in Active Surveillance

PIETRO PEPE, LUDOVICA PEPE, MICHELE PENNISI and FILIPPO FRAGGETTA

In Vivo May 2024, 38 (3) 1300-1305; DOI: https://doi.org/10.21873/invivo.13569

PIETRO PEPE

1Urology Unit, Cannizzaro Hospital, Catania, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: piepepe{at}hotmail.com

LUDOVICA PEPE

1Urology Unit, Cannizzaro Hospital, Catania, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

MICHELE PENNISI

1Urology Unit, Cannizzaro Hospital, Catania, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

FILIPPO FRAGGETTA

2Pathology Unit, Gravina and S. Pietro Hospital, Caltagirone, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Article Figures & Data

Tables

PreviousNext

In this issue

In Vivo

Vol. 38, Issue 3

May-June 2024

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Oncological Outcomes in Men With Favorable Intermediate Risk Prostate Cancer Enrolled in Active Surveillance

Message Subject (Your Name) has sent you a message from In Vivo

Message Body (Your Name) thought you would like to see the In Vivo web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 5 + 2 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Oncological Outcomes in Men With Favorable Intermediate Risk Prostate Cancer Enrolled in Active Surveillance

PIETRO PEPE, LUDOVICA PEPE, MICHELE PENNISI, FILIPPO FRAGGETTA

In Vivo May 2024, 38 (3) 1300-1305; DOI: 10.21873/invivo.13569

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Reprints and Permissions

Oncological Outcomes in Men With Favorable Intermediate Risk Prostate Cancer Enrolled in Active Surveillance

PIETRO PEPE, LUDOVICA PEPE, MICHELE PENNISI, FILIPPO FRAGGETTA

In Vivo May 2024, 38 (3) 1300-1305; DOI: 10.21873/invivo.13569

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

Cited By...

No citing articles found.

Google Scholar

Keywords

Active surveillance
prostate cancer
intermediate risk Pca

Main menu

User menu

Search

Oncological Outcomes in Men With Favorable Intermediate Risk Prostate Cancer Enrolled in Active Surveillance

Article Figures & Data

Tables

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Keywords